BridgeMD
New treatment option for Hip Arthropathy
Official title Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject
ClinicalTrials.gov ID: NCT05175300
What this study is testing
- What it's testing
- Interest of a highly cross-linked polyethylene acetabular component doped with vitamin E in total hip arthroplasty of the young and active subject.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patient aged 18 to 65 years,
- Who have signed their consent to participate in the study,
- For whom an indication for total hip arthroplasty has been given
You likely can't join if
- History of hip surgery
- Indication for a dual mobility prosthesis (obese patient, dynamic spino-pelvic anomaly)
- Hip dysplasia
- Inflammatory rheumatic disease or any other progressive concomitant condition that may impact the patient's vital or functional prognosis
- Sequelae of neurological disease or stroke
- Pregnant or breastfeeding women
See the full eligibility criteria
- Patient aged 18 to 65 years,
- Who have signed their consent to participate in the study,
- For whom an indication for total hip arthroplasty has been given
- History of hip surgery
- Indication for a dual mobility prosthesis (obese patient, dynamic spino-pelvic anomaly)
- Hip dysplasia
- Inflammatory rheumatic disease or any other progressive concomitant condition that may impact the patient's vital or functional prognosis
- Sequelae of neurological disease or stroke
- Pregnant or breastfeeding women
- Mental deficiency or any other reason that may hinder the understanding or the strict application of the protocol
- Patient likely not to return for follow-up visits
- Patient already included in another therapeutic study protocol
- Patient under court protection, guardianship or curatorship.
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.